- GlobeNewswire•4 days ago
DURHAM, N.C., Feb. 23, 2017-- Chimerix, Inc., a biopharmaceutical company committed to discovering, developing and commercializing medicines that address significant, unmet medical needs, today announced ...
- GlobeNewswire•5 days ago
--Results show higher survival rate in adenovirus-infected patients with a virologic response to brincidofovir---- Mortality rates were lower in pediatric patients than in adult patients--. DURHAM, N.C., ...
- Zacks•17 days ago
If properly implemented, such a strategy could deliver impressive returns.
CMRX : Summary for Chimerix, Inc. - Yahoo Finance
Chimerix, Inc. (CMRX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.00 x 100|
|Ask||6.50 x 800|
|Day's Range||5.21 - 5.46|
|52 Week Range||3.50 - 6.47|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.54|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|